Notice2022-20436
Fiscal Year (FY) 2022 Notice of Supplemental Funding Opportunity
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 21, 2022
Issuing agencies
Health and Human Services DepartmentSubstance Abuse and Mental Health Services Administration
Abstract
This notice is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) is supporting an administrative supplement (in scope of the parent award) up to $20,833 (total costs) for one-year to the Improving Access to Overdose Treatment grant recipients for a total of up to $104,165 (total funding). These recipients were funded in FY 2018 with a project end date of September 30, 2023. The supplemental funding will be utilized specifically to increase the number of health care providers and pharmacists who receive training and technical assistance on the prescribing of drugs or devices approved or cleared under the FDA for emergency treatment of known or suspected opioid overdose.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 182 (Wednesday, September 21, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 182 (Wednesday, September 21, 2022)]
[Notices]
[Page 57707]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-20436]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Fiscal Year (FY) 2022 Notice of Supplemental Funding Opportunity
AGENCY: Substance Abuse and Mental Health Services Administration, HHS.
ACTION: Notice of intent to award supplemental funding.
-----------------------------------------------------------------------
SUMMARY: This notice is to inform the public that the Substance Abuse
and Mental Health Services Administration (SAMHSA) is supporting an
administrative supplement (in scope of the parent award) up to $20,833
(total costs) for one-year to the Improving Access to Overdose
Treatment grant recipients for a total of up to $104,165 (total
funding). These recipients were funded in FY 2018 with a project end
date of September 30, 2023. The supplemental funding will be utilized
specifically to increase the number of health care providers and
pharmacists who receive training and technical assistance on the
prescribing of drugs or devices approved or cleared under the FDA for
emergency treatment of known or suspected opioid overdose.
FOR FURTHER INFORMATION CONTACT: Judith Ellis, Substance Abuse and
Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD
20857, telephone (240) 276-2567; email: <a href="/cdn-cgi/l/email-protection#513b24353825397f343d3d38221122303c3922307f3939227f363e27"><span class="__cf_email__" data-cfemail="39534c5d504d51175c5555504a794a5854514a581751514a175e564f">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Awardees will further collaborations with
healthcare providers and pharmacists to educate them on overdose
dangers and standing orders for FDA-approved overdose reversal drugs to
patients and individuals who support persons at high-risk for overdose.
The required activities for this supplement are as follows:
<bullet> Increase use of SAMHSA's Opioid Overdose Prevention
Toolkit as a guide to develop and implement a comprehensive prevention
program to reduce the number of prescription drug/opioid overdose-
related deaths and adverse events among cases of known or suspected
opioid overdose.
<bullet> Provide technical assistance to collaborating partner
organizations and practitioners in the implementation of a
comprehensive prevention program to reduce the number of prescription
drug/opioid overdose-related deaths and adverse events.
<bullet> Collaborate with additional pharmacies to distribute drugs
or devices approved or cleared under the Federal Food, Drug, and
Cosmetic Act for emergency treatment of known or suspected opioid
overdose, as permitted by state law.
<bullet> Provide targeted public education on the state's ``Good
Samaritan'' laws related to a drug overdose, if applicable, such as
those that permit bystanders to alert emergency responders to an
overdose or to administer drugs or devices approved or cleared under
the Federal Food, Drug, and Cosmetic Act for emergency treatment of
known or suspected opioid overdose without fear of civil or criminal
penalties.
This is not a formal request for application. Assistance will only
be provided to the Improving Access to Overdose Treatment Funding
Opportunity SP-18-006 grant recipients based on the receipt of a
satisfactory application and associated budget that is approved by a
review group.
Funding Opportunity Title: FY 2018 Improving Access to Overdose
Treatment Funding Opportunity SP-18-006.
Assistance Listing Number: 93.243.
Authority: Section 516 of the Public Health Services Act, as
amended.
Justification: Eligibility for this supplemental funding is limited
the Improving Access to Overdose Treatment Funding Opportunity SP-18-
006 grant recipients funded in FY 2018. These organizations are
uniquely positioned to provide training and technical assistance to
organizations and practitioners in prescription drug overdose
prevention activities being funded through this supplement.
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2022-20436 Filed 9-20-22; 8:45 am]
BILLING CODE 4162-20-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 21, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.